Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Vaccines01:30

Cancer Vaccines

347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

316
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
316

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High mortality at safety-net hospitals for patients with cirrhosis.

Hepatology communications·2026
Same author

Substance-induced manic psychosis in which delusions were corroborated by a chatbot - case report.

BMC psychiatry·2026
Same author

Artificial intelligence in breaking the learning curve for echocardiography: a secondary analysis of a multicentre trial.

European heart journal. Digital health·2026
Same author

An Evidence-Based Approach to Bridging Healthcare Disparities for Gastroenterological Diseases.

Digestive diseases and sciences·2026
Same author

Targeting BCMA in multiple myeloma with a trifunctional NK cell engager.

Cell reports. Medicine·2026
Same author

Advancing healthcare AI governance through a comprehensive maturity model based on systematic review.

NPJ digital medicine·2026
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

3.0K

Collaborative Innovations in Childhood Cancer Therapies.

Iris Valtingojer1, Sasha Lièvre2, Philippe Bordes3

  • 1Department of Oncology, R&D, Sanofi, Vitry-sur-Seine, France. Iris.Valtingojer@sanofi.com.

Handbook of Experimental Pharmacology
|August 23, 2024
PubMed
Summary
This summary is machine-generated.

Pediatric cancer survival has improved, but treatment innovation lags adult cancer care. Collaboration is crucial to advance pediatric cancer therapies and address unmet needs.

Keywords:
Childhood cancerCollaborationsNovel therapiesPartnershipsResearch and Development

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.5K

Related Experiment Videos

Last Updated: Jun 15, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

3.0K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.5K

Area of Science:

  • Pediatric Oncology
  • Cancer Therapeutics
  • Translational Research

Background:

  • Childhood cancer survival rates exceed 80% over 60 years, yet it remains a leading cause of disease-related death in children.
  • Most pediatric cancer survivors experience significant short- and long-term treatment toxicities.
  • Pediatric cancer treatment innovation has not kept pace with advancements seen in adult cancer therapies over the past 15 years.

Purpose of the Study:

  • To highlight the critical need for improved pediatric cancer treatment innovation.
  • To emphasize the widening therapeutic development gap between adult and pediatric oncology.
  • To advocate for enhanced collaborative efforts to accelerate progress in treating childhood cancers.

Main Methods:

  • Review of historical outcomes and current challenges in pediatric cancer care.
  • Analysis of the disparity in scientific innovation between adult and pediatric cancer treatment.
  • Identification of key areas requiring collaborative focus within the oncology community.

Main Results:

  • Significant progress in pediatric cancer survival has been achieved.
  • A notable lag in pediatric cancer treatment innovation compared to adult cancer care exists.
  • Treatment toxicity remains a major concern for pediatric cancer patients.

Conclusions:

  • Bridging the adult-pediatric therapeutic development gap requires urgent, collaborative action.
  • Prioritizing joint efforts in cancer characterization, target validation, and drug discovery is essential.
  • Enhanced collaboration is imperative to improve outcomes for children battling cancer.